Clinical trial
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
NCT00781482 is registered in ClinicalTrials.gov with Kettering Health Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
- Lead sponsor
- Kettering Health Network
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy